258 related articles for article (PubMed ID: 24586174)
1. Implication of PMLIV in both intrinsic and innate immunity.
El Asmi F; Maroui MA; Dutrieux J; Blondel D; Nisole S; Chelbi-Alix MK
PLoS Pathog; 2014 Feb; 10(2):e1003975. PubMed ID: 24586174
[TBL] [Abstract][Full Text] [Related]
2. Resistance to rabies virus infection conferred by the PMLIV isoform.
Blondel D; Kheddache S; Lahaye X; Dianoux L; Chelbi-Alix MK
J Virol; 2010 Oct; 84(20):10719-26. PubMed ID: 20702643
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
Maroui MA; Pampin M; Chelbi-Alix MK
J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
[TBL] [Abstract][Full Text] [Related]
4. [Implication of PML nuclear bodies in intrinsic and innate immunity].
Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
[TBL] [Abstract][Full Text] [Related]
5. PML positively regulates interferon gamma signaling.
El Bougrini J; Dianoux L; Chelbi-Alix MK
Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
[TBL] [Abstract][Full Text] [Related]
7. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
8. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
[TBL] [Abstract][Full Text] [Related]
9. 3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production.
Li Z; Wu Y; Li H; Li W; Tan J; Qiao W
Virol J; 2021 Dec; 18(1):255. PubMed ID: 34930370
[TBL] [Abstract][Full Text] [Related]
10. Type I IFN-Inducible Downregulation of MicroRNA-27a Feedback Inhibits Antiviral Innate Response by Upregulating Siglec1/TRIM27.
Zheng Q; Hou J; Zhou Y; Yang Y; Cao X
J Immunol; 2016 Feb; 196(3):1317-26. PubMed ID: 26700765
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
12. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
[TBL] [Abstract][Full Text] [Related]
13. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation.
Wang S; Xie F; Chu F; Zhang Z; Yang B; Dai T; Gao L; Wang L; Ling L; Jia J; van Dam H; Jin J; Zhang L; Zhou F
Nat Immunol; 2017 Jul; 18(7):733-743. PubMed ID: 28481329
[TBL] [Abstract][Full Text] [Related]
14. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
Masroori N; Merindol N; Berthoux L
Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy.
Chen D; Feng C; Tian X; Zheng N; Wu Z
Front Immunol; 2018; 9():1268. PubMed ID: 29922292
[TBL] [Abstract][Full Text] [Related]
16. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
Chelbi-Alix MK; Quignon F; Pelicano L; Koken MH; de Thé H
J Virol; 1998 Feb; 72(2):1043-51. PubMed ID: 9444998
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
18. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
[TBL] [Abstract][Full Text] [Related]
19. Effects of promyelocytic leukemia protein on virus-host balance.
Bonilla WV; Pinschewer DD; Klenerman P; Rousson V; Gaboli M; Pandolfi PP; Zinkernagel RM; Salvato MS; Hengartner H
J Virol; 2002 Apr; 76(8):3810-8. PubMed ID: 11907221
[TBL] [Abstract][Full Text] [Related]
20. Role of promyelocytic leukemia protein in host antiviral defense.
Geoffroy MC; Chelbi-Alix MK
J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
